Impact of COVID-19 Infection on the Maternal and Perinatal Outcome of Pregnancies Associated with Preeclampsia | ||||
| Evidence Based Women's Health Journal | ||||
| Article 48, Volume 12, Issue 4, November 2022, Page 374-377 PDF (300.73 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ebwhj.2022.167996.1211 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Reham Elkhateeb  ; Hesham Fares
| ||||
| Obstetrics and Gynecology Department, Faculty of Medicine, MINIA University, Egypt | ||||
| Abstract | ||||
| Objectives: To compare the severity and complications of preeclampsia in the presence and absence of COVID-19 infection Methods: A cross-sectional study was carried out at Minia Governate isolation Hospitals which have a standard procedure for monitoring and testing COVID-19. The study enrolled 345 pregnant women after considering eligibility criteria. One hundred fifteen cases were positive for COVID-19 infection compared with randomly chosen control cases with a ratio of 1:2 of COVID-19-negative pregnant women. Result: The incidence of preeclampsia in COVID-19-infected pregnant women was 31.3% (36 cases), while 42 cases in the non-COVID-19 group had preeclampsia with an incidence of 18.3%. There was a high incidence of maternal complications in the study group (ICU admission incidence was 72.2% versus 45.2%, and maternal mortality was 41.6% versus 38%). Fetal complications were higher in the study group. Conclusion: The development of preeclampsia in COVID-19 patients is associated with hazardous maternal and fetal outcomes. It increases the need for ICU admission, invasive ventilation support, maternal and perinatal mortality. | ||||
| Keywords | ||||
| COVID-19; hazardous pregnancy complications; hypertensive disorders; preeclampsia | ||||
|
Statistics Article View: 104 PDF Download: 118 |
||||
